#wegovy

[ follow ]
#semaglutide

Novo's main Ozempic plant cited for quality lapses by FDA

Novo Nordisk's plant in Denmark is facing FDA quality issues, impacting supply of popular diabetes and obesity medications Ozempic and Wegovy.

Wegovy weight loss: The science and the hype DW 10/02/2024

Wegovy and Ozempic, despite different initial purposes, have surged in popularity as weight loss solutions, enhanced by celebrity endorsements.

New Study Establishes Link Between Ozempic and Suicidal Thoughts

Semaglutide is linked to a higher risk of suicidal ideation compared to other diabetes medications.

How People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Be cautious of semaglutide overdoses; they can lead to serious health complications and hospitalization.

Unlicensed Ozempic Alternatives Are Leading to Overdoses

Gray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

Ozempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.

Novo's main Ozempic plant cited for quality lapses by FDA

Novo Nordisk's plant in Denmark is facing FDA quality issues, impacting supply of popular diabetes and obesity medications Ozempic and Wegovy.

Wegovy weight loss: The science and the hype DW 10/02/2024

Wegovy and Ozempic, despite different initial purposes, have surged in popularity as weight loss solutions, enhanced by celebrity endorsements.

New Study Establishes Link Between Ozempic and Suicidal Thoughts

Semaglutide is linked to a higher risk of suicidal ideation compared to other diabetes medications.

How People Are Overdosing on Semaglutide Drugs like Ozempic and Wegovy

Be cautious of semaglutide overdoses; they can lead to serious health complications and hospitalization.

Unlicensed Ozempic Alternatives Are Leading to Overdoses

Gray market alternatives to Ozempic and Wegovy pose serious risks, including overdosing. FDA warns of potential ill effects of compounded semaglutide.

Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes

Ozempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.
moresemaglutide
#weight-loss
from Fast Company
3 weeks ago
Miscellaneous

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

WeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.

Weight-loss drug linked to fewer COVID deaths - Harvard Gazette

Wegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.

Opinion | This Is What a Miracle Drug Looks Like. And It Only Costs $5 to Make.

GLP-1 drugs like Ozempic and Wegovy have significant impact on weight loss and reducing the risk of heart disease, stroke, and other comorbidities.

Is Wegovy Covered By Insurance? These Insurers Offer Coverage | Entrepreneur

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.
The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%.

Could weight-loss drugs like Ozempic cause depressionor help treat it?

GLP-1s, a drug class used for diabetes and weight loss, could potentially be effective in treating neurological conditions.
Wegovy and Ozempic, both containing semaglutide, have shown benefits beyond weight loss and heart protection.

WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy

WeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.

Weight-loss drug linked to fewer COVID deaths - Harvard Gazette

Wegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.

The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side Effects

GLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.

Opinion | This Is What a Miracle Drug Looks Like. And It Only Costs $5 to Make.

GLP-1 drugs like Ozempic and Wegovy have significant impact on weight loss and reducing the risk of heart disease, stroke, and other comorbidities.

Is Wegovy Covered By Insurance? These Insurers Offer Coverage | Entrepreneur

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.
The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%.

Could weight-loss drugs like Ozempic cause depressionor help treat it?

GLP-1s, a drug class used for diabetes and weight loss, could potentially be effective in treating neurological conditions.
Wegovy and Ozempic, both containing semaglutide, have shown benefits beyond weight loss and heart protection.
moreweight-loss
#ozempic

Insider Today: Austin's genius housing fix

The soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

High prices for diabetes and obesity drugs like Ozempic are jeopardizing patient access, especially among low-income and minority groups.

From dementia to heart disease: could weight-loss jabs transform chronic conditions? podcast

Drugs originally developed for diabetes show potential for weight loss and health benefits for chronic diseases related to aging.

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.

Insider Today: Austin's genius housing fix

The soaring prices of weight-loss drugs in the US lead to significant consumer challenges compared to prices in other countries.

'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing

The U.S. pays significantly higher prices for Ozempic and Wegovy compared to other countries, prompting scrutiny from Senate leaders.

Bernie Sanders grills Ozempic maker over high prices

Novo Nordisk CEO faced scrutiny in Congress over drug pricing and its moral implications for patients, especially in relation to high prices and access to medication.

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

High prices for diabetes and obesity drugs like Ozempic are jeopardizing patient access, especially among low-income and minority groups.

From dementia to heart disease: could weight-loss jabs transform chronic conditions? podcast

Drugs originally developed for diabetes show potential for weight loss and health benefits for chronic diseases related to aging.

Woman Says Her Colon Had to Be Removed After Taking Ozempic

A woman is suing Novo Nordisk after losing her colon due to complications she claims were caused by their weight loss and diabetes medications.
moreozempic
#covid-19

Wegovy reduced Covid deaths in obese patients, study finds

Wegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
from www.mercurynews.com
2 months ago

Wegovy reduced COVID deaths in obese patients, study shows

Wegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.
from www.nytimes.com
2 months ago

An Obesity Drug Prevents Covid Deaths, Study Suggests

Wegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.

Wegovy reduced Covid deaths in obese patients, study finds

Wegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.

New Study Finds Wegovy Reduces COVID Death Risk By 33 Percent

Novo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.

Wegovy reduced COVID deaths in obese patients, study shows

Wegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.

An Obesity Drug Prevents Covid Deaths, Study Suggests

Wegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.
morecovid-19
#obesity-treatment

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity
F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.
Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity.
moreobesity-treatment
#novo-nordisk

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Novo Nordisk's significant increase in Wegovy users and sales shows a growing demand for weight loss drugs.

Wegovy is no longer just a weight-loss drug

Wegovy was approved by the FDA to reduce the risk of major cardiovascular events in obese or overweight adults with established cardiovascular disease.
Wegovy has been shown to reduce the risk of major adverse cardiac events by 20%, cardiovascular death by 15%, and death from any cause by 19%.

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Novo Nordisk's significant increase in Wegovy users and sales shows a growing demand for weight loss drugs.

Wegovy is no longer just a weight-loss drug

Wegovy was approved by the FDA to reduce the risk of major cardiovascular events in obese or overweight adults with established cardiovascular disease.
Wegovy has been shown to reduce the risk of major adverse cardiac events by 20%, cardiovascular death by 15%, and death from any cause by 19%.
morenovo-nordisk
#medicare-coverage

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes
Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans.

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes
Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.
CMS guidance allows using FDA-approved medications for specific uses under Part D plans.
moremedicare-coverage

Medicare Will Start Paying for Wegovy

Medicare may cover weight-loss drug Wegovy for select members with heart disease history
Wegovy assists in weight loss and reduces cardiovascular risk by around 20%

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%
Obesity drug Wegovy is a significant advancement in weight loss medication

Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs

The North Carolina State Health Plan has decided to end coverage for weight loss medications due to rising costs.
Appetite-suppressing drugs have been effective in helping patients lose weight and may prevent heart attacks and strokes, which can lead to high hospital bills.
#Wegovy

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.
A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.
The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy.
moreWegovy
[ Load more ]